Jos Jonkers
Professor of Molecular experimental ontogenetics and cancer therapeutics
- Name
- Prof.dr. J.M.M. Jonkers
- Telephone
- +31 71 527 2727
- j.jonkers@nki.nl
- ORCID iD
- 0000-0002-9264-9792
Prof. Dr. Jos Jonkers is professor by special appointment (in cooperation with Netherlands Cancer Institute) at the Division of Drug Discovery & Safety.
More information about Jos Jonkers
Former PhD candidates
Courses
- Caput: "Model Organisms in Cancer Drug Discovery and Development"
Professor of Molecular experimental ontogenetics and cancer therapeutics
- Science
- Leiden Academic Centre for Drug Research
- LACDR/Toxicology
- Miltenburg M.H. van, Nimwegen M.J. van, Tijdens R.B., Lalai R.A., Kuiper R., Klarenbeek S., Schouten P.C., Vries A. de, Jonkers J.M.M.. & Water B. van de (2014), Mammary gland-specific ablation of focal adhesion kinase reduces the incidence of p53-mediated mammary tumour formation., British journal of cancer 110(11): 2747-2755.
- Boesten L.S.M., Zadelaar A.S.M., Nieuwkoop A. van, Hu L, Jonkers J, Water B. van de, Gijbels M.J.J., Made I. van der, Winther M.P.J. de, Havekes L.M. & Vlijmen B.J.M. van (2006), Macrophage retinoblastoma deficiency leads to enhanced atherosclerosis development in ApoE-deficient mice, The FASEB Journal 20(7): 953-955.
- Groepsleider